REGN

Regeneron Pharmaceuticals, Inc. ·Nasdaq Global Select·Healthcare
798.00 live · 2026-08-12 15:59
49.1%
Brown Bear Score
58.5%
Business Conviction Score
52.5%
Position Health Score
46.1%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +43.4% · range 555.51–812.27

The Businesswhat the company reports

Business & cash flow

FCF / assets 10.1%
OCF / assets 12.3%
FCF / revenue 34.7%
Gross margin 44.5%
ROIC 14.6%
Forward P/E 13.3

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Forward EPS growth has outpaced trailing price return by +5.2pp

Confidence 95.0/100

Takeaway Price and forward earnings growth are broadly in step; no strong valuation lean either way.

Reported earnings

Next report 2026-10-26 · consensus EPS 16.21

Q2 23 revenue: 3.16bnQ2 23 net income: 968.40mQ2 23 EPS: 8.50Q3 23 revenue: 3.36bnQ3 23 net income: 1.01bnQ3 23 EPS: 8.89Q3 23Q4 23 revenue: 3.43bnQ4 23 net income: 1.16bnQ4 23 EPS: 10.20Q1 24 revenue: 3.15bnQ1 24 net income: 722.00mQ1 24 EPS: 6.27Q1 24Q2 24 revenue: 3.55bnQ2 24 net income: 1.43bnQ2 24 EPS: 12.41Q3 24 revenue: 3.72bnQ3 24 net income: 1.34bnQ3 24 EPS: 11.54Q3 24Q4 24 revenue: 3.79bnQ4 24 net income: 917.70mQ4 24 EPS: 7.97Q1 25 revenue: 3.03bnQ1 25 net income: 808.70mQ1 25 EPS: 7.27Q1 25Q2 25 revenue: 3.68bnQ2 25 net income: 1.39bnQ2 25 EPS: 12.81Q3 25 revenue: 3.75bnQ3 25 net income: 1.46bnQ3 25 EPS: 13.62Q3 25Q4 25 revenue: 3.88bnQ4 25 net income: 844.60mQ4 25 EPS: 7.78Q1 26 revenue: 3.61bnQ1 26 net income: 727.20mQ1 26 EPS: 6.75Q1 26

Revenue Net incomeEPS (GAAP) (6.27–13.62, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 3.61bn +19.0% 727.20m 6.75 9.47 +3.9% 2026-04-29
2025-12-31 (derived) 3.88bn +2.5% 844.60m 7.78 11.44 +5.7% 2026-02-04
2025-09-30 3.75bn +0.9% 1.46bn 13.62 11.83 +21.0% 2025-10-28
2025-06-30 3.68bn +3.6% 1.39bn 12.81 2025-08-01

Earnings response

Typical move around a filing ±4.7%
On an ordinary two days ±1.4% — filings move it 3.4× as much
Direction 6 up, 5 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue -15.0% year on yearQ3 22 filed 2022-11-03: price -0.0%Q1 23 revenue +6.6% year on yearQ1 23 filed 2023-05-04: price -5.1%Q1 23Q2 23 revenue +10.5% year on yearQ2 23 filed 2023-08-03: price +4.7%Q3 23 revenue +14.5% year on yearQ3 23 filed 2023-11-02: price +3.2%Q3 23Q1 24 revenue -0.5% year on yearQ1 24 filed 2024-05-02: price +5.9%Q2 24 revenue +12.3% year on yearQ2 24 filed 2024-08-01: price +0.3%Q2 24Q3 24 revenue +10.6% year on yearQ3 24 filed 2024-10-31: price -8.6%Q1 25 revenue -3.7% year on yearQ1 25 filed 2025-04-29: price -2.0%Q1 25Q2 25 revenue +3.6% year on yearQ2 25 filed 2025-08-01: price +4.8%Q3 25 revenue +0.9% year on yearQ3 25 filed 2025-10-28: price +11.5%Q3 25Q1 26 revenue +19.0% year on yearQ1 26 filed 2026-04-29: price -3.4%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-04-29 +19.0% -3.4% -18.2%
2025-09-30 2025-10-28 +0.9% +11.5% +21.4%
2025-06-30 2025-08-01 +3.6% +4.8% -0.2%
2025-03-31 2025-04-29 -3.7% -2.0% -5.1%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Shrinking — shares retired
Diluted shares 107.7M as at 2026-03-31
Change over 1 year -3.1%
Change over 3 years -5.5%
Public float $54.80bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 761.40 — 801.98
Protective stop 735.59 (Structure, 5.9% risk)
Support 746.48 (5 touches, 6.9% away)
Resistance 818.05 (2.5% away)

Takeaway The shares are nearer the ceiling than the floor: about 2.5% below 818.05, where sellers have turned up before, and 6.9% above 746.48, where buyers have stepped in before. That floor has held 5 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 5.9% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice ABOVE the cloud | periods 6/18/36 (68% of classic 9/26/52)
LinesTenkan/Kijun BULL | cloud twist BULL
Cloud thickness92% percentile (thick — substantial structure)
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading above its cloud — a shaded band drawn from several of its own moving averages, currently 710.77 to 776.70. Being above it means the medium-term picture is pointing upwards, and that band is the first place the stock has recent support if it slips back. Its shorter-term averages agree with that. The band is unusually wide at the moment, so it marks a broad zone rather than a single level.

Trailing returns

21 days +21.6%
63 days +10.3%
126 days +5.7%
252 days +46.2%
Below 252d high1.8%

Trend context

PositionAt trend
ExtensionNormal
Trend slopeFlat
Direction of travelConverging back to trend

Takeaway The share price is close to the level its own longer-run trend suggests is fair, and that fair level is going sideways. The gap between the two has been closing. Neither is stretched far enough to stand out.

Volatility

State Expanding
Current band width30.9% of price
Recent tightest12.2% (9 sessions ago, narrower than 38.0% of its history)
Expansion since2.52×
Band 611.59 — 835.29

Takeaway Lately this share price has been swinging around inside a range roughly 31% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 649.81–808.052026-07-032026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

REGN: no binary-event flag. Near IV 27%, far IV 21% (ratio 1.28), implied move 3.4%.

Implied volatility 27% near (9d) · 21% far (65d) — Term structure inverted — the market is pricing an event in the near window
Term structure 1.28× near/far
Historical volatility 34%
Implied vs historical 0.81×
Implied move ±3.4% by 2026-08-21
Implied move vs ATR 0.42×
Skew Put Skew (1.49×)
Call wall 800.00 (+0.2% away)
Put wall 600.00 (-24.8% away)
Gamma pin 600.00
  • Term structure inverted (near 27% IV vs far 21% IV, ratio 1.28)

Takeaway Insuring against a move in this stock costs more for the next few weeks than for the next few months. Traders usually pay up like that when they know something is coming soon — results, a court ruling, a regulatory decision. Options traders are positioned for a move of around 3.4% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Leadership Cooling

Rotation health 80.5/100; Strong Rotation Tailwind.

Rotation health 80.5
Rotation strength 64.6
LegQuadrantRS-RatioRS-Mom
Stock vs sector Leading 116.7 108.7
Stock vs SPY Leading 116.7 108.1
Sector vs SPY Improving 86.4 102.1

Direction of travel: North-East / strengthening leadership

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 4/9 (+5.0)
  • Altman Z-score 13.10 (+10.0)
  • Insider conviction score (+3.0)
  • Gross margin quality: 44.5% (+9.0)
  • ROIC quality: 14.6% (+8.2)
  • FCF margin quality: 34.7% (+20.0)
  • FCF margin improving by 3.6 pts (+2.0)
  • High earnings quality (accrual ratio -0.012) (+2.0)
  • Accrual ratio improving (-0.00 -> -0.01) (+5.0)
  • Relative Strength 13.4% vs sector: OUTPERFORMING (+10.0)
  • Track 1: MACD histogram state (7.67) (+8.0)
  • Track 1: relative strength trend improving (+5.0)
  • Track 1: 20-day momentum acceleration 0.12 (+9.0)
  • Track 1: bullish DI spread 45.7 (+8.0)
  • Track 1: ADX 50.4 and rising (+10.0)
  • Track 1: relative momentum rank 0.81 (+4.0)
  • Track 1: EMA20 reclaim distance 8.2% (+1.4)
  • Track 1: EMA20 slope improving 5.2% (+5.0)
  • Track 1: positive MACD regime (+3.0)
  • Track 1: MACD line/signal repair quality (+8.0)
  • Track 1: MACD slope improving (+5.0)
  • Track 1: VPT strength 0.08 (+1.7)
  • Track 1: price above EMA50 by 14.0% (+5.0)
  • Track 1: EMA50 slope improving 5.7% (+3.0)
  • Track 1: Bollinger position 0.83 (+1.3)

Negative signals

  • Track 1: weak volume confirmation (0.57x average)
  • Track 1: MACD histogram deteriorating (-2.53)
  • Track 1: RSI deterioration/extension 91.7, 5-day change +13.4
  • Chase risk 46.1/100 (Elevated Chase Risk): RSI 91.7, EMA20 8.2%, EMA50 14.0%, BB 0.83, distribution 5.5/100
  • Gross margin improving by -41.7 pts (+-3.0)
  • Chase risk 46.1/100 | Extension score 53.9/100 | Elevated Chase Risk